Joshua S. Boger Increases Stake in CervoMed Inc. to 19.99% Following Private Placement

Joshua S. Boger, Ph.D., Chairperson of the Board of CervoMed Inc. (CRVO), filed an amendment to his Schedule 13D on June 15, 2026, reporting a significant increase in beneficial ownership. Following a private placement that closed on June 11, 2026, Boger may be deemed to beneficially own 2,204,143 shares, representing approximately 19.99% of the company's outstanding common stock. This position includes 2,012,682 shares held directly or through the JSB 2021 Trust and ASB 2021 Trust, as well as 23,541 exercisable stock options and 167,920 shares acquirable via Series B and Series C Warrants. The reported ownership is capped at 19.99% due to a Maximum Ownership Limitation clause within the warrants, which prevents exercise if it would cause the holder to exceed this threshold. The private placement involved the JSB 2021 Trust purchasing 955,414 units at $3.14 per unit. Boger has also entered into a customary lock-up agreement restricting the transfer of these shares for a specified period.